P3 Health Partners
PIII
20 hedge funds and large institutions have $3.31M invested in P3 Health Partners in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
134% more capital inflows, than outflows
Capital inflows: $1.16M | Capital outflows: $498K
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
18% more funds holding
Funds holding: 17 → 20 (+3)
1.82% more ownership
Funds ownership: 7.39% → 9.22% (+1.8%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$405K |
| 2 |
HRT Financial
New York
|
+$295K |
| 3 |
MYDA Advisors
Woodmere,
New York
|
+$149K |
| 4 |
Scientech Research LLC
Jersey City,
New Jersey
|
+$121K |
| 5 |
Renaissance Technologies
New York
|
+$113K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$217K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$65.5K |
| 3 |
Nine Masts Capital
Central,
Hong Kong
|
-$55.3K |
| 4 |
Diversified Trust
Memphis,
Tennessee
|
-$51.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$41.2K |
PIII Hedge Fund Activity: Q2 2026 in Review
20 of the 8,369 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q2 2026, worth a combined $3.31M — up 341% from $750K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PIII positions and 4 closed out — a net gain of 3 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $405K. The largest seller was Vanguard Capital Management, cutting an estimated $217K.
- 20 institutional investors held P3 Health Partners (PIII) as of Q2 2026, up from 17 in Q1 2026.
- Funds reported $3.31M of P3 Health Partners stock for Q2 2026, up 341% quarter-over-quarter.
- 7 funds opened new P3 Health Partners positions in Q2 2026 and 4 closed out, a net change of +3 holders.
- The largest P3 Health Partners buyer in Q2 2026 was Jane Street, an estimated $405K added.
- The largest P3 Health Partners seller in Q2 2026 was Vanguard Capital Management, an estimated $217K sold.
Based on aggregated 13F filings for Q2 2026.